OIG finds $72 million in MA and Part D payments tied to excluded or felony-convicted providers
Oct 11, 2026 edition · GC-2026-0142 · Published 2026-10-11 · Version 3 · Announced
OIG identifies preclusion-process vulnerabilities behind $72 million in plan payments associated with revoked NPIs. Its data brief distinguishes timing and ownership issues from a dispensing-pharmacy regulatory gap and makes no specific CMS recommendations.
What happened
The report was issued September 28 and posted October 1. OIG examined 1,017 NPIs associated with providers revoked from Medicare Parts A and B who were absent from the Preclusion List during 2022 and 2023. It identified $72 million in Part C and Part D payments to 249 of those NPIs during 2022 through 2024. The different analysis and payment periods matter: the reported payment total is not limited to the two years used to select the NPI population.
OIG attributes the vulnerabilities to timing problems and errors when providers were added to or removed from the list, and to omission of some organizations whose owners were excluded or had felony convictions. It also says current regulations do not subject pharmacies that only fill prescriptions, without prescribing Part D drugs, to preclusion. The brief offers information for possible future regulatory or guidance solutions and contains no specific CMS recommendations. It does not announce that revocation and preclusion are interchangeable or impose a new blanket recoupment instruction on plans.
Scope and timing
- Authority status
- Announced
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
- Affected functions
- Provider Enrollment, Managed Care, Compliance, Revenue Cycle
- Responsible owner
- Provider Enrollment
Why it matters
Enrollment revocation, exclusion and preclusion are distinct. The summary also identifies a regulatory gap for dispensing-only pharmacies; it does not order blanket recovery of every payment.
Recommended action
Enrollment and managed-care owners should reconcile applicable status sources, investigate discrepancies and obtain counsel review of payment consequences. These are internal control recommendations.
Implementation playbook
- Reconcile provider-status sources and investigate discrepancies. Internal target. Provider Enrollment · Due 2026-10-18
- Review affected payments with counsel, without assuming a blanket repayment order. Internal target. Compliance · Due 2026-10-18
Sources
- MA organizations and prescription drug plans paid $72 million for services associated with excluded providers or certain felony convictionsOfficial · HHS OIG · 2026-10-01 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →